Cargando…

Evaluation of Synaptic and Axonal Dysfunction Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment Based on CSF and Bioinformatic Analysis

Synaptic loss and dysfunction are one of the earliest signs of neurodegeneration associated with cognitive decline in Alzheimer’s disease (AD) and other neurodegenerative diseases. This study aimed to assess the relationships between biological processes of the synaptic pathology underlying AD, mole...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dulewicz, Maciej, Kulczyńska-Przybik, Agnieszka, Borawska, Renata, Słowik, Agnieszka, Mroczko, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502777/ https://www.ncbi.nlm.nih.gov/pubmed/36142780 http://dx.doi.org/10.3390/ijms231810867

Ejemplares similares

Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer’s Disease
por: Dulewicz, Maciej, et al.
Publicado: (2021)

Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease
por: Doroszkiewicz, Julia, et al.
Publicado: (2023)

Fatty Acid Binding Protein 3 (FABP3) and Apolipoprotein E4 (ApoE4) as Lipid Metabolism-Related Biomarkers of Alzheimer’s Disease
por: Dulewicz, Maciej, et al.
Publicado: (2021)

The Relationships between Cerebrospinal Fluid Glial (CXCL12, CX3CL, YKL-40) and Synaptic Biomarkers (Ng, NPTXR) in Early Alzheimer’s Disease
por: Kulczyńska-Przybik, Agnieszka, et al.
Publicado: (2023)

The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases
por: Kulczyńska-Przybik, Agnieszka, et al.
Publicado: (2021)

Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis
por: Kulczyńska-Przybik, Agnieszka, et al.
Publicado: (2022)

Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
por: Dulewicz, Maciej, et al.
Publicado: (2022)

Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Dulewicz, Maciej, et al.
Publicado: (2020)

Biochemical Markers in Alzheimer’s Disease
por: Rabbito, Alessandro, et al.
Publicado: (2020)

The Implication of Reticulons (RTNs) in Neurodegenerative Diseases: From Molecular Mechanisms to Potential Diagnostic and Therapeutic Approaches
por: Kulczyńska-Przybik, Agnieszka, et al.
Publicado: (2021)

Biomarkers of Activity-Dependent Plasticity and Persistent Enhancement of Synaptic Transmission in Alzheimer Disease: A Review of the Current Status
por: Warpechowski, Marcin, et al.
Publicado: (2023)

Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis of Alzheimer's Disease
por: Doroszkiewicz, Julia, et al.
Publicado: (2022)

The Significance of Selected C-C Motif Chemokine Ligands in Colorectal Cancer Patients
por: Zajkowska, Monika, et al.
Publicado: (2022)

Eotaxins and Their Receptor as Biomarkers of Colorectal Cancer
por: Zajkowska, Monika, et al.
Publicado: (2021)

CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer
por: Zajkowska, Monika, et al.
Publicado: (2023)

YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s Disease
por: Muszyński, Paweł, et al.
Publicado: (2017)

The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis—A Literature Review
por: Kulikowska, Joanna, et al.
Publicado: (2021)

Amyloid and Tau Protein Concentrations in Children with Meningitis and Encephalitis
por: Sulik, Artur, et al.
Publicado: (2022)

The Significance of CXCL1 and CXCL8 as Well as Their Specific Receptors in Colorectal Cancer
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2020)

CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression
por: Pączek, Sara, et al.
Publicado: (2020)

Investigating the Role of Serum and Plasma IL-6, IL-8, IL-10, TNF-alpha, CRP, and S100B Concentrations in Obstructive Sleep Apnea Diagnosis
por: Fiedorczuk, Piotr, et al.
Publicado: (2023)

Serum CXCL8 and Its Specific Receptor (CXCR2) in Gastric Cancer
por: Pawluczuk, Elżbieta, et al.
Publicado: (2021)

Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
por: Litman-Zawadzka, Ala, et al.
Publicado: (2020)

The Significance of CXCL1 and CXCR1 as Potential Biomarkers of Colorectal Cancer
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2023)

Optimized RT-qPCR and a novel normalization method for validating circulating miRNA biomarkers in ageing-related diseases
por: Want, Andrew, et al.
Publicado: (2023)

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
por: Papaliagkas, Vasileios, et al.
Publicado: (2023)

A Disintegrin and Metalloproteinase (ADAM) Family: Their Significance in Malignant Tumors of the Central Nervous System (CNS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2021)

Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?
por: Bloniecki, Victor, et al.
Publicado: (2020)

CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer’s disease
por: Qiang, Qiang, et al.
Publicado: (2022)

Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2014)

Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer’s Disease (AD): A Meta-Analysis of CSF Markers
por: Manyevitch, Roni, et al.
Publicado: (2018)

Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics
por: Trushina, Eugenia, et al.
Publicado: (2013)

Depressive symptoms and CSF Alzheimer's disease biomarkers in relation to clinical symptom onset of mild cognitive impairment
por: Chan, Carol K., et al.
Publicado: (2020)

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Yulan, et al.
Publicado: (2021)

Association of CSF GAP-43 and APOE ε4 with Cognition in Mild Cognitive Impairment and Alzheimer’s Disease
por: Zhu, Yueli, et al.
Publicado: (2022)

Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis
por: Zhou, Futao, et al.
Publicado: (2023)

Higher baseline levels of CSF inflammation increase risk of incident mild cognitive impairment and Alzheimer's disease dementia
por: Contreras, Joey A., et al.
Publicado: (2022)

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
por: Duits, Flora H., et al.
Publicado: (2018)

Retinal microvasculature dysfunction is associated with Alzheimer’s disease and mild cognitive impairment
por: Chua, Jacqueline, et al.
Publicado: (2020)

Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer’s disease
por: Baldeiras, Inês, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f7f5nk47uflfihnlr96jdbvv9g